S ince the time that Spiegel and colleagues introduced stereotactic devices for the treatment of humans, there have been many advances in stereotactic procedures for treating neurological diseases, including Parkinson's disease (PD), essential tremor (ET), chronic neuropathic pain, and obsessive-compulsive disorder (OCD).
nance-guided focused ultrasound surgery (MRgFUS) is currently being tested in human clinical trials to determine its efficacy and safety for treating ET, PD, chronic neuropathic pain, and OCD. 1, 3, 5, 13, 14 The currently available results suggest that MRgFUS achieves a high success rate with a very low rate of permanent complications. However, when temperature in the target area fails to increase in some patients, lesioning is not achieved. This failure occurs in only a small proportion of patients who undergo MRgFUS, and there is no available information regarding potential reasons. In this study, we analyzed various patient-and treatment-related factors during MRgFUS and tried to identify the factors associated with poor treatment outcomes.
methods
This study was conducted under the permission and supervision of the Severance Hospital institutional review board (Seoul, Korea). We retrospectively reviewed data from patients who underwent MRgFUS at our institute. For MRgFUS of ET, we choose the ventralis intermedius nucleus of the thalamus as a target region. 3 The bilateral anterior capsules were targeted for treatment of OCD, and the posteroventral aspect of the globus pallidus interna was lesioned to treat idiopathic PD. During the procedures, we elevated the sonication energy in a stepwise fashion until patients experienced sufficient symptom improvement or until the temperature did not increase even with higher sonication energy. The inclusion criteria for this study were patients who completed MRgFUS in which there was a maximum temperature (Tmax) at the target area of 50°C or greater on MR thermometry and clearly visible lesions on postoperative MRI. Data from 25 patients (15 with ET, 1 with idiopathic PD, and 9 with OCD) were used for this study.
We collected patient-specific and treatment-related data. The patient factors included sex, age, skull volume in treatment area, and skull density ratio (SDR). The SDR was defined as the ratio between the mean values in Hounsfield units for marrow and cortical bone, which was calculated as follows: 1) The planned locations of the target and the transducer were marked on CT scans, and the surface of the skull was subdivided into small sections. 2) For each skull subsection, multiple parallel rays were created and the CT values along each ray were used to create local density profiles. 3) For each profile, the trabecular CT value (local minimum CT value in the profile) and the cortex CT value (average of inner and outer cortices) were computed. 4) The "local" SDR was the average of the ratios between the trabecular and cortex CT values of all of the profile samples.
Treatment-related parameters included skull area in the treatment field, average skull thickness, total number of elements actually used during treatment, and number of sonication elements that penetrated the skull by an incidence angle larger than 25°. Both patient-and treatmentrelated factors were compared with the target area Tmax measured by MR thermometry.
For 
results
Initially, we attempted to treat 28 patients with MRgFUS. However, 3 patients with ET failed to show a sufficient temperature increase (< 50°C). Although this failure may have resulted from patient-or treatmentrelated factors, other factors including technical failure or device malfunction may have also played a role because these patients underwent MRgFUS in the early stage of the study period. Therefore, data from these patients were excluded from this study to facilitate analysis, as a temperature increase over 50°C guaranteed that ultrasonic energy was successfully transmitted into the skull, even though Tmax varied among patients.
The mean Tmax (range) was 55.4°C (52°C-62°C). The mean Tmax values for MRgFUS thalamotomy and anterior capsulotomy were 55.1°C (53°C-62°C) and 55.4°C (52°C-61°C), respectively. There was no statistical difference in Tmax between the two procedure types (MannWhitney U-test, p = 0.907; Table 1 ).
The analysis of Tmax and patient-related factors indicated that skull volume in the treatment area and SDR were closely correlated with Tmax. Skull volume and Tmax were negatively correlated (p = 0.023, r 2 = 0.206, y = 64.156 -0.028x), and SDR and Tmax were positively correlated (p = 0.009, r 2 = 0.263, y = 49.643 + 11.832x). Other factors such as age and sex were not associated with Tmax ( Fig. 1) . However, skull volume showed correlation with mean skull thickness, which implies that mean skull thickness could be useful for predicting the degree of Tmax, if more data were available ( Table 2) .
None of the treatment-related factors were significantly related to Tmax during MRgFUS, although the number of elements during sonication tended to correlate with Tmax without exhibiting statistical significance (p = 0.065, r 2 = 0.141, y = 39.112 + 0.018x) ( Table 3) .
We also analyzed the relationship between maximal energy required to achieve Tmax (Emax) and SDR-skull volume (Figs. 2 and 3). SDR and skull volume appeared to have a positive and negative correlation with Emax, respectively. Although there was no clear evidence of SDR or skull volume as a determinant for energy requirement to achieve sufficient Tmax, lower sonication energy appeared to be required for SDR > 0.45 and skull volume < 320 cm 
discussion
In this study, we tried to identify the factors affecting temperature increase during MRgFUS, and our results indicate that skull volume and SDR in the treatment field seem to be closely related to temperature increase. During thermal lesioning, the degree of temperature increase is crucial for successful treatment. Generally the extent of thermal lesioning is determined by two factors: the degree of Tmax and the duration of Tmax. For example, 1 second at 57°C is known to be sufficient for tissue necrosis, whereas for tissue necrosis with a Tmax of 54°C, 3 seconds is needed. 18 Similar to other modalities for thermal lesioning, MRgFUS also could modulate the duration of Tmax by increasing the duration of sonication. However, the degree of Tmax showed limitations even with higher sonication energy. Because this phenomenon can directly affect the treatment results, identifying the factors related to temperature increase is crucial for selecting patients and improving treatment outcomes. In this study, it appeared that patient-related factors, particularly SDR and skull volume, more than treatment-related factors appeared to have been more correlated to energy transmission across the skull.
development of treatment technologies for stereotactic and Functional Neurosurgery
There have been various advances in procedures and technologies since neurosurgical interventions were first applied to treat CNS diseases. In the early 1990s, neurosurgical interventions for functional brain diseases were performed by open craniotomy and resection or disconnection of cortical areas. 2, 9, 10 Although the efficacy of this techniques was acceptable, the associated mortality and morbidity rates were high, which limited the wide use of these procedures. Once Spiegel and colleagues invented the human stereotactic frame, it became possible to perform deep brain neurosurgical procedures with high accuracy and precision. This technical innovation changed neurosurgical procedures for functional brain diseases such as movement disorders, epilepsy, and psychiatric ill- ness, including attempts at generating focal lesions in target areas. Different modalities have been used for lesioning. RF ablation is widely performed because it can generate precise lesions with high reliability, but postoperative hemorrhages in deep brain nuclei or cortical areas have been reported in up to 35% of patients who undergo RF lesioning. 22 Because infection and anesthesia-related complications also contribute to the surgical risk, the overall complication rate after RF lesioning should be considered, and safer modalities have been emphasized, especially for surgeries in patients with functional disorders. Gamma Knife radiosurgery was developed as a minimally invasive technique capable of precisely generating a focal lesion in the brain, and early candidates for its application were functional disorders including cancer pain and some psychiatric illnesses. 6, 12 Although Gamma Knife radiosurgery, especially in Gamma Knife thalamotomy, have achieved an efficacy similar to RF lesioning for movement disorders, there are important issues to consider, including the time interval between treatment and effect, variability of the target area reaction, and inability to predict side effects for specific patients. 4, 17 Furthermore, the complication rate associated with Gamma Knife radiosurgery in patients with movement disorders has been reported to be as high as 50%, although the reported complications were not fatal. 
recent clinical trials with mrgFus: potential and limitations
Progressive innovation in radiographic modalities and technical developments has enabled ultrasonic energy to be focused through the skull, leading to the application of MRgFUS for functional neurosurgery. Several clinical trials have examined the use of MRgFUS for thalamotomy. 3, 16 Reporting on the 1-year follow-up results for 15 patients who underwent MRgFUS thalamotomy, Elias et al. indicated that there were no hemorrhagic complications and only 1 serious adverse event, dysesthesia affecting a patient's index finger. 5 Similarly, we previously reported that minimally invasive MRgFUS thalamotomy was effective and safe, but in some of our patients, the MRgFUS-induced thermal increase was not sufficient to create a lesion. 3 Although an appropriate temperature increase was easily achieved with relatively low ultrasonic energy in some patients, others required higher ultrasonic energy to elevate the target area temperature.
Factors related to thermal rise: sdr and skull volume
Scarce information regarding thermal increase was available during the clinical trial, and we assumed that skull variability might be related to the differences in thermal increase. We therefore measured the skull volume in the treatment area and found that temperature increase could be affected by skull volume. In the present study, we collected more data from other MRgFUS trials, which confirmed that skull volume in the treatment area was closely related to the thermal increase during MRgFUS surgery (p = 0.023, r 2 = 0.206, y = 64.156 -0.028x). Although further investigation is needed to define skull volume cutoff values, this result suggests that measurement of skull volume should be an essential step when selecting candidates for MRgFUS.
Another factor found to limit energy transfer throughout the skull was SDR. As mentioned above, SDR is defined as the mean value for the ratio of Hounsfield units of marrow and cortical bone in the treatment area, with a lower SDR indicating that the Hounsfield unit value for cortical bone is much higher than that for bone marrow. When ultrasonic energy impacts different media, 3 different patterns of action are observed: absorption, reflection, and attenuation. 20 All 3 effects can interrupt focused ultrasonic energy. It could thus be postulated that a larger skull volume results in a less temperature increase because bone absorbs ultrasonic energy at a rate 100 times higher than that of soft tissue. Reflection between different tissues also can reduce ultrasonic energy, and energy reflection is correlated with different acoustic impedances for various materials and the incidence angle of ultrasonic energy. Considering that acoustic impedance is calculated by multiplying the tissue density by the conduction velocity in tissue, the density difference within the skull can also affect energy reflection and contribute to the reduced temperature increase in patients with lower SDR (p = 0.009, r 2 = 0.263, y = 49.643 + 11.832x) (Fig. 4) . We did not observe a correlation between the incidence angle and temperature increase (p = 0.798), which could indicate that the incidence angle during MRgFUS surgery was not sufficient to cause reflection and affect focusing energy; however, further investigation is needed to test this hypothesis.
energy requirement for tmax according to sdr and skull volume
Emax also should be considered before and during MRgFUS treatment because higher energy requirements could be problematic. There are 2 main parameters for modulating Emax during MRgFUS treatment: sonication power and sonication duration. Although tissue responses to increasing sonication power and duration may show some differences, increase in sonication power and duration could cause overheating of the skin/skull and prolonged treatment time may result in incomplete lesioning because of treatment intolerance of the patients. According to our results, both SDR and skull volume appeared to be related to Emax (Figs. 2 and 3) . Because of insufficient sample size, we could not determine the cutoff values for SDR and skull volume recommendations for minimizing Emax. Nevertheless, it could be postulated that skull vol- ume less than 330 cm 3 and/or SDR higher than 0.45 may predict a lower energy requirement during MRgFUS.
conclusions
MRgFUS was introduced as a minimally invasive functional neurosurgical option, and recent trials have suggested acceptable clinical outcomes. However, the temperature increase associated with target area lesioning varies among patients. In the current study, we tried to identify the factors affecting temperature increase during MRgFUS. Our results indicate that skull volume and SDR in the treatment field seem to be closely related to temperature increase. This information would be expected to be helpful for the selection of patients for MRgFUS surgery and also for the optimization of the treatment outcomes. 
